MRI  Vol.1 No.1 , August 2012
Hydroperoxides and cytokines as biomarkers in detecting atherosclerosis predisposition in cigarette smokers
Objectives: Smoking increases oxidative modification of LDL, associated with lower HDL plasma levels, systemic inflammatory response and endothelial dysfunction. We tested the hypothesis that the risk status for coronary atherosclerosis disease (CAD) of cigarettes smokers might be identified by means of serum oxidative levels and vascular inflammation determination. Design and Methods: Oxidative stress levels, cytokines, and the metabolic status were investigated on 499 subjects admitted to our institute. The association between biomarkers and smoking habits in the presence/absence of disease and with the number of vessel affected, was studied. Results: Oxidative stress and inflammatory levels (p < 0.001) were strongly induced by smoking habits. Serum values of the subjects categorised as CAD, non CAD and healthy subjects differed significantly (p < 0.001) only for the degree of oxidative stress. Glycaemia was able to affect C-reactive protein serum levels with a positive association (p < 0.05). The analysis of the study population indicated that serum oxidative stress levels significantly increased with increasing number of vessels affected (p < 0.01). When statistical analysis was performed separately in both smoking groups, smokers did not show any particular difference for both oxidative stress and inflammation markers between the two groups of cardiovascular patients (CAD and non CAD) and the control group, while for non smokers, the differences were evident. Conclusion: These findings indicate that the considered biomarkers, especially oxidative stress, can be useful to predict the biological damage caused by cigarette smoking, as well as to identify subjects characterised by a higher risk of cardiovascular event, but cannot evaluate the presence of disease in subjects with smoking habit.

Cite this paper
Lubrano, V., Ballardin, M., Longo, V., Paolini, M. and Scarpato, R. (2012) Hydroperoxides and cytokines as biomarkers in detecting atherosclerosis predisposition in cigarette smokers. Modern Research in Inflammation, 1, 11-17. doi: 10.4236/mri.2012.11002.
[1]   Starek A, and Podolak (2009) Carcinogenic effect of to-bacco smoke Rocz Panstw Zakl Hig.;60(4):299-310.

[2]   Nazaroff, W.W., and Singer, B.C. (2004) Inhalation of hazardous air pollutants from environmental tobacco smoke in US residences J Expo Anal Environ Epidemiol.;14 Suppl 1:S71-7.

[3]   Heitzer, T. and Meinertz, T. (2000) Prevention of coronary heart disease: smoking. Z Kardiol.94 Suppl 3, III/30-42.

[4]   Ambrose, JA, and Barua, RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update J Am Coll Cardiol. 2004 May 19;43(10):1731-7.

[5]   Czernin, J., Sun, K., Brunken, R., et al. (1995) Effect of acute and long-term smoking on myocardial blood flow and flow reserve. Circulation Jun 15 91(12):2891-7.

[6]   Ip, J.H., Fuster, V., Badimon, L., et al. (1990) Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol. Jun 15(7):1667-87.

[7]   Poreba, R., Skoczynska, A., Derkacz, A (2004). Effect of tobacco smoking on endothekial function in patients with coronary arteriosclerosis. Pol Arch Med Wewn Jan 111(1): 27-36

[8]   Palombo, C., Lubrano, V., Sampietro, T (1999). Oxidative stress, F2-isoprostanes and endothelial dysfunction in hypercholesterolemia. Cardiovasc Res. Dec 44(3):474-6.

[9]   Banerjee, M., Kang, K.H., Morrow, J.D., et al. (1992). Effects of a novel prostaglandin, 8-epi-PGF2 alpha, in rabbit lung in situ. Am J Physiol. Sep 263(3 Pt 2): H660-3.

[10]   Wilson, S.H., Best, P.J., Lerman, L.O., et al. (1999). En-hanced coronary vasoconstriction to oxidative stress product, 8-epi-prostaglandinF2 alpha, in experimental hypercholesterolemia. Cardiovasc Res. Dec 44(3):601-7.

[11]   Morrow, J.D., Frei, B., Longmire, A.W. et al. (1995) Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med. May 4 332(18):1198-203.

[12]   Yura, T., Fukunaga, M., Khan, R et al. (1999) Free-radical-generated F2-isoprostane stimulates cell proliferation and endothelin-1 expression on endothelial cells. Kidney Int. Aug 56(2):471-8.

[13]   Fukunaga, M., Yura, T., Badr, K.F. (1995) Stimulatory effect of 8-Epi-PGF2 alpha, an F2-isoprostane, on endothelin-1 release. J Cardiovasc Pharmacol., 26 Suppl 3:S51-2.

[14]   Friedewald, W.T., Levy, R.I., Fredrickson, D.S (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin ChemJun 18(6): 499-502.

[15]   Alberti, A., Bolognini, L., Macciantelli, D., et al. (2000) The radical cation of N,N-diethyl-para-phenylendiamine: a possible indicator of oxidative stress in biological samples. Res Chem intermed; 26: 253-67

[16]   Lubrano, V., Vassalle, C., L’Abbate, A., et al.. A new method to evaluate oxidative stress in humans. Immuno analyse & Biologie Spécialisée 2002, June 17 (3) : 172-175

[17]   De Sutter, J., De Buyzere, M., Gheeraert, P., et al. (2001) Fibrogen and C-reactive protein on admission as markers of final infart size after primary angioplasty for acute myocardial infarctio. Atherosclerosis ; 157: 189-196

[18]   Buffon, A., Liuzzo, G., Biasucci, M.L., et al. (1999) A Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary an-gioplasty. JACC June 28;34(5):1512-21

[19]   Hoidal, J.R. and Niewoehner, D.E. (1983) Pathogenesis of emphysema. Chest; 83: 679-685.

[20]   Kannel, W.B. (1981) Update on the role of cigarette smoking in coronary artery disease. Am Heart J; 101:319-328

[21]   Church, D.F. and Pryor, W.A. (1985) Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 64:111-126.

[22]   Prieme, H., Loft, S., Klarlund, M., et al. (1998) Effect of smoking cessation on oxidative DNA modification esti-mated by 8-oxo-7,8-dihydro-2'-deoxyguanosine excretion Carcinogenesis. Feb 19(2):347-51.

[23]   Yokode, M., Kita, T., Arai, H., et al Cholesteryl ester accumulation in macrophages incubated with low density lipoprotein pretreated with cigarette smoke extract. Proc Natl Acad Sci U S A 1988; 85:2344-2348

[24]   Frei, B., Forte, T.M., Ames, B.N., et al. (1991) Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma: protective effects of ascorbic acid. Biochem; 277:133-138

[25]   Schectman, G., Byrd, J.C., Gruchow, H.W. (1989) The influence of smoking on vitamin C status in adults. Am J Public Health; 79:158-162.

[26]   Rimm, E.B., Stampfer, M.J., Ascherio, A., et al. (1993) Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med; 328:1450-1456

[27]   Singh, R.B., Niazma, Bishnol, Z., et al. (1994) Diet anti-oxidant vitamins, oxidative stress and risk of coronary artery disease: the Peerzada Prospective Study. Acta Car-diol. 49: 453-497

[28]   Morrow, J., Frei, B., Longmire, A., et al. (1995) Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med. 332:1198–1203.

[29]   Penn, A. and Snyder, C.A. (1993) Inhalation of sidestream cigarette smoke accelerates development of arteriosclerotic plaques. Circulation.88:1820–1825.

[30]   Knight-Lozano, C.A., Young, C.G., Burow D.L., et al. (2002) Cigarette smoke exposure and hypercholesterole-mia increase mitochondrial damage in cardiovascular tis-sues. Circulation. 105: 849–854.

[31]   Ramos, K.S., Zhang, Y., Sadhu, D.N., et al. (1996) The induction of proliferative vascular smooth muscle cell phenotypes by benzo(a)pyrene is characterized by up-regulation of inositol phospholipid metabolism and c-Ha-ras gene expression. Arch Biochem Biophys. ; 332:213–222.

[32]   Ou, X., and Ramos K.S. Proliferative responses of quail aortic smooth muscle cells to benzo[a]pyrene: implications in PAH-induced atherogenesis. Toxicology 1992 ; 74:243–258.

[33]   Lubrano, V., Cocci, F., Battaglia, D., et al. (2005) Use-fulness of high-sensitivity IL-6 measurement for clinical characterization of patients with coronary artery disease J Clin Lab Anal.; 19(3):110-4.